Primary diffuse large B-cell lymphoma of the prostate: a case report and review of the literature
Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures....
Saved in:
Published in | Journal of medical case reports Vol. 15; no. 1; pp. 1 - 546 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
03.11.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. Case presentation In this article, we report a case of primary diffuse large B-cell lymphoma of the prostate in a 70-year-old Asian man who presented with symptoms of urinary tract obstruction. Histological and immunocytochemical studies of transurethral biopsy of the prostate showed diffuse large B-cell lymphoma. The patient was managed by a combination of eight courses of chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and radiotherapy. Post-chemotherapy computed tomography scans showed complete remission. He remained disease free, until now, 15 months after the end of therapy. We also reviewed and analyzed relevant literature to illustrate the diagnosis, treatment, and prognosis of this disease. Conclusion Diffuse large B-cell non-Hodgkin's lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. Keywords: Prostate, Diffuse large B-cell lymphoma, Lower urinary tract symptoms, Case report |
---|---|
AbstractList | Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. Diffuse large B-cell non-Hodgkin's lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. Case presentation In this article, we report a case of primary diffuse large B-cell lymphoma of the prostate in a 70-year-old Asian man who presented with symptoms of urinary tract obstruction. Histological and immunocytochemical studies of transurethral biopsy of the prostate showed diffuse large B-cell lymphoma. The patient was managed by a combination of eight courses of chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and radiotherapy. Post-chemotherapy computed tomography scans showed complete remission. He remained disease free, until now, 15 months after the end of therapy. We also reviewed and analyzed relevant literature to illustrate the diagnosis, treatment, and prognosis of this disease. Conclusion Diffuse large B-cell non-Hodgkin's lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. Keywords: Prostate, Diffuse large B-cell lymphoma, Lower urinary tract symptoms, Case report Abstract Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. Case presentation In this article, we report a case of primary diffuse large B-cell lymphoma of the prostate in a 70-year-old Asian man who presented with symptoms of urinary tract obstruction. Histological and immunocytochemical studies of transurethral biopsy of the prostate showed diffuse large B-cell lymphoma. The patient was managed by a combination of eight courses of chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and radiotherapy. Post-chemotherapy computed tomography scans showed complete remission. He remained disease free, until now, 15 months after the end of therapy. We also reviewed and analyzed relevant literature to illustrate the diagnosis, treatment, and prognosis of this disease. Conclusion Diffuse large B-cell non-Hodgkin’s lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. Case presentation In this article, we report a case of primary diffuse large B-cell lymphoma of the prostate in a 70-year-old Asian man who presented with symptoms of urinary tract obstruction. Histological and immunocytochemical studies of transurethral biopsy of the prostate showed diffuse large B-cell lymphoma. The patient was managed by a combination of eight courses of chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and radiotherapy. Post-chemotherapy computed tomography scans showed complete remission. He remained disease free, until now, 15 months after the end of therapy. We also reviewed and analyzed relevant literature to illustrate the diagnosis, treatment, and prognosis of this disease. Conclusion Diffuse large B-cell non-Hodgkin’s lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. BACKGROUNDPrimary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. CASE PRESENTATIONIn this article, we report a case of primary diffuse large B-cell lymphoma of the prostate in a 70-year-old Asian man who presented with symptoms of urinary tract obstruction. Histological and immunocytochemical studies of transurethral biopsy of the prostate showed diffuse large B-cell lymphoma. The patient was managed by a combination of eight courses of chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and radiotherapy. Post-chemotherapy computed tomography scans showed complete remission. He remained disease free, until now, 15 months after the end of therapy. We also reviewed and analyzed relevant literature to illustrate the diagnosis, treatment, and prognosis of this disease. CONCLUSIONDiffuse large B-cell non-Hodgkin's lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. Abstract Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of reported cases. Due to its low prevalence, there has been a chronic lack of targeted diagnostic guidelines and treatment procedures. Case presentation In this article, we report a case of primary diffuse large B-cell lymphoma of the prostate in a 70-year-old Asian man who presented with symptoms of urinary tract obstruction. Histological and immunocytochemical studies of transurethral biopsy of the prostate showed diffuse large B-cell lymphoma. The patient was managed by a combination of eight courses of chemotherapy with a regimen including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and radiotherapy. Post-chemotherapy computed tomography scans showed complete remission. He remained disease free, until now, 15 months after the end of therapy. We also reviewed and analyzed relevant literature to illustrate the diagnosis, treatment, and prognosis of this disease. Conclusion Diffuse large B-cell non-Hodgkin’s lymphoma originating in the prostate is a rare and highly aggressive disease that lacks specificity in its clinical presentation and is easily misdiagnosed. This disease should be considered clinically in patients with significant prostate enlargement and insignificant prostate-specific antigen elevation. The diagnosis can be clarified with a prostate puncture biopsy. Chemotherapy is the main treatment for patients and may be supplemented with surgical treatment and radiotherapy. |
ArticleNumber | 546 |
Audience | Academic |
Author | Liu, Yanli Ren, Mengwei |
Author_xml | – sequence: 1 fullname: Ren, Mengwei – sequence: 2 fullname: Liu, Yanli |
BookMark | eNptks1q3DAUhU1JaZJpX6ArQ6F041R_tqwuCmnoTyDQLtq1uCNfzWiwrakkp-Rt8ix5ssozQ8iUooXE1XePOFfnvDgZ_YhF8ZqSC0rb5n2knNVNRRitCKeCV_xZcUZlzSqqhDx5cj4tzmPcEFI3reIvilMuJJNK8bPC_AhugHBXds7aKWLZQ1hh-aky2Pdlfzds136A0tsyrbHcBh8TJPxQQmkg0wG3PqQSxu7hPuCtwz8H9OG-dwkDpCngy-K5hT7iq8O-KH59-fzz6lt18_3r9dXlTWVqSVOlqACLVkrDO8J5zRRRUhghKTLRWkoZKGKMaRvRIDBAozq1XIqaGhBt1_FFcb3X7Txs9HZvTHtwelfwYaUhJGd61A1rDNisSaQRLeOtkl2zBFlLy5HBMmt93Gttp-WAncExBeiPRI9vRrfWK3-r27qpSf6MRfHuIBD87wlj0oOL81BhRD9FzWrFCWu5mNE3_6AbP4Uxj2qmFGt24CO1gmzAjdbnd80sqi-bNjsRYkdd_IfKq8PBmZwf63L9qOHtk4Y1Qp_W0fdTcn6MxyDbgyaHIAa0j8OgRM951Ps86pxHvcuj5vwv6sXSyQ |
CitedBy_id | crossref_primary_10_1093_jscr_rjad598 crossref_primary_10_1016_j_radcr_2023_02_055 crossref_primary_10_1002_iju5_12541 crossref_primary_10_1016_j_asjsur_2023_03_040 |
Cites_doi | 10.1007/s11805-007-0129-1 10.1056/NEJMra2027612 10.1590/S1677-55382006000100010 10.1056/NEJM199309303291402 10.1016/0090-4295(88)90241-5 10.1016/S0022-5347(01)67330-0 10.1002/(SICI)1097-0142(19980815)83:4<732::AID-CNCR15>3.0.CO;2-T 10.1056/NEJMoa1807315 10.1159/000457117 10.1200/JCO.19.00172 10.1016/S0140-6736(20)31366-0 10.1016/S0022-5347(17)53297-8 10.1016/j.clon.2012.02.004 10.1200/JCO.19.01389 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION 3V. 7RV 7X7 7XB 88C 88E 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M0T M1P NAPCQ PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13256-021-03143-3 |
DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Nursing & Allied Health Premium Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1752-1947 |
EndPage | 546 |
ExternalDocumentID | oai_doaj_org_article_626caff1107c4823897d6ba757f3e2ab A681104428 10_1186_s13256_021_03143_3 |
GroupedDBID | --- -5E -5G -A0 -BR 0R~ 29L 2WC 3V. 4.4 53G 5GY 5VS 7RV 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACRMQ ADBBV ADINQ ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS AQUVI BAPOH BAWUL BCNDV BENPR BFQNJ BKEYQ BMC BPHCQ BVXVI C24 C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M0T M1P MK0 M~E NAPCQ O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP WOQ WOW AFGXO ABVAZ AFNRJ 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c571t-914afef77c3d0335290974c471e248f112a90ccc8646ea2aec9d9bb451ca48dd3 |
IEDL.DBID | RPM |
ISSN | 1752-1947 |
IngestDate | Fri Oct 04 13:12:57 EDT 2024 Tue Sep 17 20:57:20 EDT 2024 Fri Aug 16 01:20:26 EDT 2024 Thu Oct 10 18:05:48 EDT 2024 Thu Feb 22 23:39:13 EST 2024 Fri Feb 02 04:28:16 EST 2024 Tue Aug 20 22:11:47 EDT 2024 Thu Sep 12 16:32:18 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c571t-914afef77c3d0335290974c471e248f112a90ccc8646ea2aec9d9bb451ca48dd3 |
Notes | ObjectType-Case Study-3 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Review-1 ObjectType-Feature-5 ObjectType-Report-2 ObjectType-Article-4 |
ORCID | 0000-0002-9752-3275 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565014/ |
PMID | 34727993 |
PQID | 2599263028 |
PQPubID | 2040215 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_626caff1107c4823897d6ba757f3e2ab pubmedcentral_primary_oai_pubmedcentral_nih_gov_8565014 proquest_miscellaneous_2593028344 proquest_journals_2599263028 gale_infotracmisc_A681104428 gale_infotracacademiconefile_A681104428 gale_healthsolutions_A681104428 crossref_primary_10_1186_s13256_021_03143_3 |
PublicationCentury | 2000 |
PublicationDate | 2021-11-03 |
PublicationDateYYYYMMDD | 2021-11-03 |
PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-03 day: 03 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Journal of medical case reports |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | DE Ezekwudo (3143_CR6) 2017; 10 LH Sehn (3143_CR14) 2020; 38 R Advani (3143_CR15) 2018; 379 K Fukutani (3143_CR9) 2003; 94 International Non-Hodgkin's Lymphoma Prognostic Factors Project (3143_CR19) 1993; 329 CA Alvarez (3143_CR11) 2006; 32 WF Whitmore (3143_CR8) 1982; 128 XD Zhou (3143_CR3) 2019; 25 LS King (3143_CR5) 1951; 27 K Kerbl (3143_CR18) 1988; 32 A Sarris (3143_CR1) 1995; 153 P Armand (3143_CR17) 2019; 37 3143_CR10 A Jafari (3143_CR12) 2019; 16 JS Abramson (3143_CR13) 2020; 396 DH Wright (3143_CR2) 2012; 24 DG Bostwick (3143_CR4) 1998; 83 T Fang (3143_CR7) 2007; 4 LH Sehn (3143_CR16) 2021; 384 |
References_xml | – volume: 4 start-page: 129 year: 2007 ident: 3143_CR7 publication-title: Chin J Clin Oncol doi: 10.1007/s11805-007-0129-1 contributor: fullname: T Fang – volume: 384 start-page: 842 year: 2021 ident: 3143_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMra2027612 contributor: fullname: LH Sehn – volume: 32 start-page: 64 year: 2006 ident: 3143_CR11 publication-title: Int Braz J Urol doi: 10.1590/S1677-55382006000100010 contributor: fullname: CA Alvarez – ident: 3143_CR10 – volume: 329 start-page: 987 year: 1993 ident: 3143_CR19 publication-title: N Engl J Med doi: 10.1056/NEJM199309303291402 contributor: fullname: International Non-Hodgkin's Lymphoma Prognostic Factors Project – volume: 27 start-page: 801 year: 1951 ident: 3143_CR5 publication-title: Am J Pathol contributor: fullname: LS King – volume: 32 start-page: 347 year: 1988 ident: 3143_CR18 publication-title: Urology doi: 10.1016/0090-4295(88)90241-5 contributor: fullname: K Kerbl – volume: 153 start-page: 1852 year: 1995 ident: 3143_CR1 publication-title: J Urol doi: 10.1016/S0022-5347(01)67330-0 contributor: fullname: A Sarris – volume: 94 start-page: 621 year: 2003 ident: 3143_CR9 publication-title: Nihon Hinyokika Gakkai zasshi contributor: fullname: K Fukutani – volume: 25 start-page: 340 year: 2019 ident: 3143_CR3 publication-title: Zhonghua Nan Ke Xue contributor: fullname: XD Zhou – volume: 83 start-page: 732 year: 1998 ident: 3143_CR4 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19980815)83:4<732::AID-CNCR15>3.0.CO;2-T contributor: fullname: DG Bostwick – volume: 379 start-page: 1711 year: 2018 ident: 3143_CR15 publication-title: N Engl J Med doi: 10.1056/NEJMoa1807315 contributor: fullname: R Advani – volume: 10 start-page: 199 year: 2017 ident: 3143_CR6 publication-title: Case Rep Oncol doi: 10.1159/000457117 contributor: fullname: DE Ezekwudo – volume: 38 start-page: 155 year: 2020 ident: 3143_CR14 publication-title: J Clin Oncol doi: 10.1200/JCO.19.00172 contributor: fullname: LH Sehn – volume: 396 start-page: 839 year: 2020 ident: 3143_CR13 publication-title: Lancet doi: 10.1016/S0140-6736(20)31366-0 contributor: fullname: JS Abramson – volume: 128 start-page: 953 year: 1982 ident: 3143_CR8 publication-title: J Urol doi: 10.1016/S0022-5347(17)53297-8 contributor: fullname: WF Whitmore – volume: 16 start-page: 412 year: 2019 ident: 3143_CR12 publication-title: Urol J contributor: fullname: A Jafari – volume: 24 start-page: 319 year: 2012 ident: 3143_CR2 publication-title: Clin Oncol (R Coll Radiol) doi: 10.1016/j.clon.2012.02.004 contributor: fullname: DH Wright – volume: 37 start-page: 3291 year: 2019 ident: 3143_CR17 publication-title: J Clin Oncol doi: 10.1200/JCO.19.01389 contributor: fullname: P Armand |
SSID | ssj0056893 |
Score | 2.3049698 |
SecondaryResourceType | review_article |
Snippet | Abstract
Background
Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in... Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small... Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small number of... BACKGROUNDPrimary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in a small... Abstract Background Primary lymphoma of the prostate is an exceedingly rare disease, with diffuse large B-cell lymphoma being the most common known subtype in... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 1 |
SubjectTerms | Abdomen Anthracyclines Antigens Biopsy Bone marrow Cancer Cancer therapies Case Report Case reports Chemotherapy CT imaging Cyclophosphamide Diffuse large B-cell lymphoma Lower urinary tract symptoms Lymphatic system Lymphoma Magnetic resonance imaging Medical prognosis Non-Hodgkin's lymphomas Patients Prednisone Prostate Prostate cancer Radiation therapy Radiotherapy Rare diseases Urination Urogenital system Urology Vincristine |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbhQxDI5QD6iXCmirDrQQJCQO1ai7SSbJ9NYiqgqpiAOVeoucnxFIy2zV3T3wNn2WPhl2MrvqwIFLrxPPaGLH9ufEdhj7ICPCTt-pWibpa2VjrKGLsp6AlRFMJ0VLhcJXX_Xltfpy09w8uuqLcsJKe-DCuBME3AG6jsKUoCw6mNZE7cE0-J0kwGfrO23WwVSxwY1GN7wukbH6ZIExV0PJtpQ-hAihliM3lLv1_2uT_86TfOR4Ll6wnQEx8rPypy_Zs9S_Ys-vhjPxXRa-lYYRnO46WS0Sn1FyNz-vaU-ez36juOa_gM87jliP31KVB-LLUw48oAfj5dCAQx8f7ksdy0D6cD_btFzeY9cXn79_uqyHqxPq0JjpEk2Ygi51xgQUBpVVtRMMHAJ6oiSURW4KaCchBKuVTiAghTa23qtmSl3OY5T7bKuf9-mAcRDGJgPgdYxoVYUFnbyK02hl0MFAxY7XnHS3ZcIuRxZWu8J3h3x3me9OVuycmL2hpO7W-QHK3A0yd_-TecXekahcKRXd6Kg70xbfURhRVexjpiAtRdEFGIoNcErU72pEeTiiRO0K4-H1cnCDdi8choyt0HJCw-83w_QmZaz1ab7KNEQglaqYGS2j0dzHI_3PH7nDt0WYjbHr66dg1hu2LWjh01a4PGRby7tVOkIgtfRvs878ATV-HZU priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Public Health Database dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NaxQxFA9aQbyInzi2agTBgwzdnWSSjBdpi6UIFQ8WegsvH6OFdWbt7h763_teJjM6Cl43b1iS9_V7yftg7I0ICDtdK0sRhSulCaGENohyAUYE0K2oGioUPv-szi7kp8v6Ml-4bXJa5WgTk6EOvac78kOE6U2lBLrDD-ufJU2NotfVPELjNruzRMGk0Q3mZErxqBU647FQxqjDDUZeNaXcUhIR4oRSzJxR6tn_r2X-O1vyD_dz-oDdz7iRHw2Mfshuxe4Ru3ueX8YfM_gytI3gNPFkt4l8RSne_Likm3m-ukGm9T-A9y1HxMfXVOuBKPM9B-7Rj_Hh6YBDF_hQzDJSrqa2y0_YxenHrydnZR6fUPpaL7doxiS0sdXaI0OotKpZYPDg0RvFSpoWgRY0C--9UVJFqCD6JjTOyXpJnc5DEE_ZXtd38RnjUGkTNYBTIaBlrQyo6GRYBiO88hoK9m48R7setmtTdGGUHU7d4qnbdOpWFOyYjnqipA7X6Yf--pvNCmMx0PLQthSeemkQWDQ6KAe6RvmJFbiCvSJG2aFcdNJTe6QMfiMxqirY20RBmoqM85ALDnBL1PNqRnkwo0QN8_PlURhs1vCN_S2PBXs9LdOXlLXWxX6XaIhASFkwPROi2d7nK93V99Tl2yDUxvj1-f__fJ_dq0ig6aJbHLC97fUuvkCYtHUvky78AiqKEjs priority: 102 providerName: ProQuest |
Title | Primary diffuse large B-cell lymphoma of the prostate: a case report and review of the literature |
URI | https://www.proquest.com/docview/2599263028 https://search.proquest.com/docview/2593028344 https://pubmed.ncbi.nlm.nih.gov/PMC8565014 https://doaj.org/article/626caff1107c4823897d6ba757f3e2ab |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9swFBdtB2OX0X0xb12mwWCH4SaxZEnerQktZZASxgq5CX15LSR2aJLD_pv-Lf3L-p5sh3m77eKD9QSW39fvSe89EfKZeYCdtuQpC8ymXHmfmtKzdGQU80aWLCuwUHh2JS6v-fdFvjggeVcLE5P2nb09rZar0-r2JuZWrldu2OWJDeezqQIUAtB-eEgOJWNdiN6Y31yAB-6qY5QYbiDcyjHPFjOHABykeHMO4-C2i4L1nFHs2f-vZf47W_IP93NxTJ63uJGeNd_3ghyE6iV5OmtPxl8RN2_aRlC88WS3CXSJKd50kuLOPF3-BqbVK0PrkgLio2us9QCU-Y0a6sCP0ebogJrKP9w31Swt6cP9ct94-TW5vjj_Ob1M2wsUUpfL8RYMGTdlKKV0wBIsripGED448Ech46oEqGWKkXNOCS6CyUxwhS-s5fkYe517z96Qo6quwltCTSZVkMZY4T3Y1kwZESz3Y6-YE06ahHzt_qReNwvWMb5QQjcs0MACHVmgWUIm-LP3lNjjOr6o737pltMaQi1nyhIDVMcVQItCemGNzEGCQmZsQj4iq3RTMLrXVH0mFMzhEFcl5EukQF0F1jnTlhzAkrDrVY_ypEcJOub6w5046FbHNxoCxyITbITDn_bDOBPz1qpQ7yINEjDOEyJ7YtRbe38ExD72-W7F_N1_z3xPnmUo-LgLzk7I0fZuFz4AhtraAWjOQsJTTccD8mRyfjX_MYj7EYOoTY_qdCI1 |
link.rule.ids | 230,315,733,786,790,870,891,2115,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,43343,43612,43838,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJ8FeEJ8iMJiRkHhA0drYsR1e0Io2FVirCW3S3izHdgCpS8raPvDfc5c4hYDEa31R5fv8nX13BnjNPcLOshIpD7xMhfY-tZXn6dhq7q2qeFZQo_B8IWeX4tNVfhUP3NaxrLL3ia2j9o2jM_IjhOlFJjmGw_erHym9GkW3q_EJjduwRyM39Qj2pieL8y-9L84lhuO-VUbLozXmXjkV3VIZESKFlA_CUTu1_1_f_He95B8B6PQ-3IvIkR13on4At0L9EO7M4934I7Dn3eAIRm-ebNeBLanIm01TOptny58otubasqZiiPnYiro9EGe-Y5Y5jGSsuzxgtvasa2fpKZe7wcuP4fL05OLDLI0PKKQuV5MNOjJhq1Ap5VAk1FxVjDF9cBiPQiZ0hVDLFmPnnJZCBpvZ4ApflKXIJzTr3Hv-BEZ1U4enwGymdFDWltJ79K2ZtjKUwk-85k46ZRN42_PRrLrtmja_0NJ0XDfIddNy3fAEpsTqHSXNuG5_aG6-mmgyBlMtZ6uKElQnNEKLQnlZWpWjBoXMlgkckqBM1zC6s1RzLDV-IzCvSuBNS0G2ioJzNrYc4JZo6tWA8mBAiTbmhsu9Mpho42vzWyMTeLVbpi-pbq0OzbalIQIuRAJqoESDvQ9X6u_f2jnfGsE2ZrDP_v_nh3B3djE_M2cfF5-fw35Gyk3H3vwARpubbXiBoGlTvoyW8QtOzxbP |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUXylMNFGokJA4om93YsR1ubWFVHlvtgUoVF8uvQMVusuruHsqv6W_pL2Mmj1VTbr3GYynOjGe-ib8ZE_KOeYCdtuAxC8zGXHkfm8KzeGgU80YWLM2xUHhyIo5P-dez7OzGVV81ad_Z80E5mw_K8981t3Ixd0nHE0umkyMFKASgfbLwRXKfPIA9m8ouUW-ccCYgDnc1MkokS0i6MmTbIn8IIEKM9-cwDsE7z1kvJNWd-__3z7c5kzeC0HiH_Oxev-Ge_BmsV3bg_t7q7Hin9T0mj1poSg8akSfkXiifku1Je_j-jLhp05mC4qUq62WgM2SR08MYf_7T2SXYRTU3tCoogEq6wHISALIfqaEOQiVtTieoKf31VVMw04peX802vZ2fk9Px5x9Hx3F7R0PsMjlaga_kpgiFlA60jvVb-RAyFAchL6RcFYDmTD50zinBRTCpCS73ubU8G2E7de_ZC7JVVmXYJdSkUgVpjBXeg_tOlRHBcj_yijnhpInIh05NetEsWNcpjBK60a8G_epav5pF5BA1uZHENtr1g-ril24_toZszpmiwBzYcQXoJZdeWCMzMNKQGhuRfbQD3dSkbpyBPhAK5nBI3SLyvpZAdwB24Uxb1QBLwsZaPcm9niRsY9cf7mxNt25kqSE3zVPBhjj8djOMM5EaV4ZqXcugAOM8IrJno72190fA8upW4q2lvbzzzH2yPf001t-_nHx7RR6muMHwnzvbI1uri3V4DYhtZd_Ue_MfnatCZQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Primary+diffuse+large+B-cell+lymphoma+of+the+prostate%3A+a+case+report+and+review+of+the+literature&rft.jtitle=Journal+of+medical+case+reports&rft.au=Ren%2C+Mengwei&rft.au=Liu%2C+Yanli&rft.date=2021-11-03&rft.eissn=1752-1947&rft.volume=15&rft.issue=1&rft.spage=546&rft.epage=546&rft_id=info:doi/10.1186%2Fs13256-021-03143-3&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1752-1947&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1752-1947&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1752-1947&client=summon |